Paul Tudor Jones Vir Biotechnology, Inc. Transaction History
Tudor Investment Corp Et Al
- $19.2 Billion
- Q2 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 67,904 shares of VIR stock, worth $496,378. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,904
Previous 64,815
4.77%
Holding current value
$496,378
Previous $656,000
7.93%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VIR
# of Institutions
233Shares Held
87.6MCall Options Held
231KPut Options Held
132K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$122 Million1.37% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$93.9 Million0.0% of portfolio
-
State Street Corp Boston, MA5.09MShares$37.2 Million0.0% of portfolio
-
Baillie Gifford & CO3.92MShares$28.7 Million0.03% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $970M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...